##gff-version 3
##sequence-region P51636 1 162
P51636	UniProtKB	Chain	1	162	.	.	.	ID=PRO_0000004772;Note=Caveolin-2	
P51636	UniProtKB	Topological domain	1	86	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51636	UniProtKB	Intramembrane	87	107	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51636	UniProtKB	Topological domain	108	162	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51636	UniProtKB	Modified residue	19	19	.	.	.	Note=Phosphotyrosine%3B by SRC;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12091389,ECO:0000269|PubMed:15504032;Dbxref=PMID:12091389,PMID:15504032	
P51636	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9WVC3	
P51636	UniProtKB	Modified residue	23	23	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18081315;Dbxref=PMID:18081315	
P51636	UniProtKB	Modified residue	27	27	.	.	.	Note=Phosphotyrosine%3B by SRC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15504032;Dbxref=PMID:15504032	
P51636	UniProtKB	Modified residue	36	36	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18081315;Dbxref=PMID:18081315	
P51636	UniProtKB	Alternative sequence	1	13	.	.	.	ID=VSP_018696;Note=In isoform Beta. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P51636	UniProtKB	Alternative sequence	51	112	.	.	.	ID=VSP_038114;Note=In isoform C. LGFEDVIAEPVTTHSFDKVWICSHALFEISKYVMYKFLTVFLAIPLAFIAGILFATLSCLHI->DFNAFCKDLPNGSAFSADNMEECDRCYHCSIVYERRTMLLFCQPATEPGLNTWTPGLEIGIL;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P51636	UniProtKB	Alternative sequence	113	162	.	.	.	ID=VSP_038115;Note=In isoform C. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P51636	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_012071;Note=Q->E;Dbxref=dbSNP:rs8940	
P51636	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Greatly reduced Src-mediated phosphorylation and binding of RASA1%2C SRC and NCK1. Completely eliminates Src-mediated tyrosine phosphorylation and binding to RASA1%2C SRC and NCK1%3B when associated with A-27. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15504032;Dbxref=PMID:15504032	
P51636	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Abolishes phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18081315;Dbxref=PMID:18081315	
P51636	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Greatly reduced Src-mediated phosphorylation and binding of RASA1%2C SRC and NCK1. Completely eliminates Src-mediated phosphorylation and binding of RASA1%2C SRC and NCK1%3B when associated with A-19. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15504032;Dbxref=PMID:15504032	
P51636	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Abolishes phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18081315;Dbxref=PMID:18081315	
